BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29126851)

  • 1. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.
    Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G
    J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated IL-17A secretion and CCR6 co-expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients.
    Long Y; Zhao X; Xia C; Li X; Fan C; Liu C; Wang C
    Scand J Immunol; 2020 Jun; 91(6):e12842. PubMed ID: 31660620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RORγt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
    Kaneko S; Kondo Y; Yokosawa M; Furuyama K; Segawa S; Tsuboi H; Kanamori A; Matsumoto I; Yamazaki M; Sumida T
    Mod Rheumatol; 2018 Sep; 28(5):814-825. PubMed ID: 29251019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CCR6/CCL20 axis expands RORγt
    Herrnstadt GR; Niehus CB; Ramcke T; Hagenstein J; Ehnold LI; Nosko A; Warkotsch MT; Feindt FC; Melderis S; Paust HJ; Sivayoganathan V; Jauch-Speer SL; Wong MN; Indenbirken D; Krebs CF; Huber TB; Panzer U; Puelles VG; Kluger MA; Steinmetz OM
    Kidney Int; 2023 Jul; 104(1):74-89. PubMed ID: 36924892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Role for IL-6 Receptor Classic Signaling: Induction of ROR
    Hagenstein J; Melderis S; Nosko A; Warkotsch MT; Richter JV; Ramcke T; Herrnstadt GR; Scheller J; Yan I; Mittrücker HW; Kluger MA; Steinmetz OM
    J Am Soc Nephrol; 2019 Aug; 30(8):1439-1453. PubMed ID: 31311828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.
    Skovdahl HK; Damås JK; Granlund AVB; Østvik AE; Doseth B; Bruland T; Mollnes TE; Sandvik AK
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
    Zhang XX; Kang XM; Zhao AM
    Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa.
    Cook KW; Letley DP; Ingram RJ; Staples E; Skjoldmose H; Atherton JC; Robinson K
    Gut; 2014 Oct; 63(10):1550-9. PubMed ID: 24436142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.
    Loiseau C; Requena M; Mavigner M; Cazabat M; Carrere N; Suc B; Barange K; Alric L; Marchou B; Massip P; Izopet J; Delobel P
    Mucosal Immunol; 2016 Sep; 9(5):1137-50. PubMed ID: 26883727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.
    Turner JE; Paust HJ; Steinmetz OM; Peters A; Riedel JH; Erhardt A; Wegscheid C; Velden J; Fehr S; Mittrücker HW; Tiegs G; Stahl RA; Panzer U
    J Am Soc Nephrol; 2010 Jun; 21(6):974-85. PubMed ID: 20299360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris.
    Asothai R; Anand V; Das D; Antil PS; Khandpur S; Sharma VK; Sharma A
    Immunobiology; 2015 Oct; 220(10):1129-35. PubMed ID: 26093920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
    González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
    J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.